Client: Pluristem Date: March 2017
Pluristem© developed a convenient, automated thawing device, for use by clinicians at point of care, which offers a reliable and simple thawing method that can safeguard the integrity of the supply chain.
This is key to maintaining the potency and consistency of a cell product, because, unlike many traditional drugs, cell therapies must be thawed before being administered to a patient.
However, the most commonly used thawing procedure can stress the cells and even result in cell injury or death, thereby reducing potency and the ability to administer consistent doses. Furthermore, the standard method requires that water come into direct contact with product packaging, thereby increasing the risk of contamination.
In order to deliver sterile, standardized doses, Pluristem© have developed a thawing device to be used with the vials that contain our products.